Besides directly inducing tumor cell apoptosis, type I IFNs and IFN-γ promote anti-tumor immunity via multiple mechanisms—i.e., directly activating T-cells and activating natural killer cells along with dendritic cells to cross-prime CD8 T-cells. Here, CD8A is linked to neoplasm.